State Farm Research and Development Center

EQS-News: Deutsche Rohstoff AG: Prime Lithium AG reserves strategic site for potential lithium production and welcomes chemicals executive as CEO and co-founder

Retrieved on: 
Thursday, December 7, 2023
DAX, Dow Chemical Company, Dow, Bayer, Verbund, Herty Advanced Materials Development Center, Research, Lanxess, State Farm Research and Development Center, Security (finance), Lithium

Deutsche Rohstoff AG announces significant progress in Prime Lithium AG’s recent developments.

Key Points: 
  • Deutsche Rohstoff AG announces significant progress in Prime Lithium AG’s recent developments.
  • Prime Lithium is a 88% subsidiary of Deutsche Rohstoff.
  • Deutsche Rohstoff AG founded Prime Lithium AG in 2021 to position itself in the rapidly growing battery value chain in Germany (see press release dated 21 March 2022).
  • He has acquired 12% of the shares in Prime Lithium, making him the company’s sole shareholder alongside Deutsche Rohstoff AG.

Imply Introduces a Developer Center for Analytics and Application Innovation

Retrieved on: 
Tuesday, October 31, 2023
Data Analytics, Data Management, Professional Services, Technology, Software, Knowledge, UI, State Farm Research and Development Center, Prince (musician), Jump start, Documentation, Architecture, Organization, Druid, Polaris, Learning, Ecosystem, PMC, Apache, Apache Druid, Tourism

Imply, the company founded by the original creators of Apache Druid, is excited to announce the launch of its Developer Center .

Key Points: 
  • Imply, the company founded by the original creators of Apache Druid, is excited to announce the launch of its Developer Center .
  • Imply’s Developer Center has been meticulously designed with the developer community in mind.
  • “This Developer Center is a significant milestone in our ongoing commitment to providing a great developer experience,” said Gian Merlino, PMC chair for Apache Druid and CTO/co-founder of Imply.
  • To explore the Developer Center and join our thriving developer community, visit www.imply.io/developer .

DriveNets Network Cloud-AI - the Highest-Performance AI Ethernet Solution - is available for order with Broadcom Jericho 3-AI Based White Boxes

Retrieved on: 
Tuesday, October 17, 2023
Cloud, GPU, Broadcom Inc., NIC, ASIC, Organization, Florida Small Business Development Center Network, Open Compute Project, AT&T, DriveNets, DDC, Intel, Ecosystem, Growth, Scala, Architecture, HPE, State Farm Research and Development Center, Software, OCP, Graphics processing unit, AT, Medical device, Dairy, Video game, Accton Technology Corporation, AI, Research, JCT

This second AI networking solution from DriveNets is based on Network Cloud-AI which was introduced in May supporting white boxes based on Broadcom's Jericho 2C+.

Key Points: 
  • This second AI networking solution from DriveNets is based on Network Cloud-AI which was introduced in May supporting white boxes based on Broadcom's Jericho 2C+.
  • Built on DriveNets' Network Cloud – which is deployed in the world's largest networks, DriveNets Network Cloud-AI supports the highest-performance, fully scheduled networking system based on open standard Ethernet.
  • DriveNets Network Cloud-AI was validated by leading hyperscalers in early trials as the top performing Ethernet solution for AI networking.
  • The availability of Network Cloud-AI software and Jericho 3-AI based white boxes allows builders of AI infrastructures to have a highest-performance, fully scheduled networking system available in the market today, based on open standard Ethernet.

Accton Announces 800G-Optimized Products that Provide Ethernet and VoQ Fabrics for AI/ML Workloads

Retrieved on: 
Tuesday, September 12, 2023
Semiconductor, Technology, Software, Networks, Internet, Hardware, Cloud, Ethernet, OSFP, DDC, Breathy voice, ML, TBPS, TWSE, DAC, QSFP28, NCP, QSFP56, Architecture, Broadcom Inc., NCF, AI, Hyperscale computing, State Farm Research and Development Center, FCS, Boeing Satellite Development Center, Video game, Accton Technology Corporation, Research

Accton Technology Corporation (Accton) (TWSE: 2345), a leading provider of networking and communications solutions, today announced a series of 800G-optimized products that can provide Ethernet-based fabric and Virtual Output Queue (VoQ) based fabric for AI/ML workloads.

Key Points: 
  • Accton Technology Corporation (Accton) (TWSE: 2345), a leading provider of networking and communications solutions, today announced a series of 800G-optimized products that can provide Ethernet-based fabric and Virtual Output Queue (VoQ) based fabric for AI/ML workloads.
  • AI networks require high-capacity systems in a flat architecture that can handle large amounts of data with low latency and high throughput.
  • To meet the demands of AI/ML workloads, either Ethernet-based fabrics or VoQ-based fabrics are being adopted to reduce job completion time.
  • Accton’s 51.2 Tbps Broadcom StrataXGS® Tomahawk® 5 series-based system with 64x800G or 128x400G ports provides a high-radix, deployment-friendly Ethernet-fabric.

Tonix Pharmaceuticals Initiates Phase 1 Trial of TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers

Retrieved on: 
Wednesday, August 16, 2023
Autoimmune disease, Hematopoietic stem cell transplantation, Etanercept, Therapy, FC, Hook effect, Adalimumab, Denosumab, State Farm Research and Development Center, Toxicity, Autoimmunity, UCB, Animal, Infliximab, RDC, Mab, Sanofi, Protein engineering, Thrombosis, ADC, Merck, Research, CD40L, TL1A, Jeju Free International City Development Center, RANKL, Generic drug, Pharmaceutical industry, Safety, Tonix Pharmaceuticals, Pharmacokinetics

CHATHAM, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the initiation of a Phase 1 single ascending dose escalation study of TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody or mAb) in healthy volunteers. The primary objectives of the study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous (IV) TNX-1500.

Key Points: 
  • The primary objectives of the study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous (IV) TNX-1500.
  • TNX-1500 is in development for the prevention of kidney transplant rejection and other potential transplant and autoimmune disorder indications.
  • Initiation of this first-in-human study is intended to support dosing in a planned Phase 2 trial in kidney transplant recipients.
  • Our ability to develop and advance protein therapeutics is facilitated by our Research and Development Center (RDC) in Frederick, Md.

Masan Group named among Best Companies to Work for in Asia 2023 by HR Asia

Retrieved on: 
Monday, August 7, 2023
TEAM, Friends, Accountability, Mentorship, Policy, Multimedia, Creativity, Integrity, State Farm Research and Development Center, Masan Group, Inclusion, Growth, Bias, Society, Training, Environment, Family, Nursing, Management, Creative industries

HO CHI MINH CITY, Vietnam, Aug. 6, 2023 /PRNewswire/ -- During the recent HR Asia Awards, Masan Group was recognized with two prestigious honors.

Key Points: 
  • HO CHI MINH CITY, Vietnam, Aug. 6, 2023 /PRNewswire/ -- During the recent HR Asia Awards, Masan Group was recognized with two prestigious honors.
  • The "Best Place to Work in Asia" award is a highly esteemed international accolade presented annually by HR Asia, the premier magazine on human resources in Asia.
  • It aims to assess and recognize businesses with outstanding HR policies, attractive remuneration packages, and the most exemplary working environments in the region.
  • The assessment was based on three fundamental factors: Core (strategy-structure), Self (individual), and Group (collective).

Masan Group named among Best Companies to Work for in Asia 2023 by HR Asia

Retrieved on: 
Monday, August 7, 2023
TEAM, Friends, Accountability, Mentorship, Policy, Creativity, Integrity, State Farm Research and Development Center, Masan Group, Inclusion, Growth, Bias, Society, Training, Environment, Family, Nursing, Management, Creative industries

HO CHI MINH CITY, Vietnam, Aug. 7, 2023 /PRNewswire/ -- During the recent HR Asia Awards, Masan Group was recognized with two prestigious honors.

Key Points: 
  • HO CHI MINH CITY, Vietnam, Aug. 7, 2023 /PRNewswire/ -- During the recent HR Asia Awards, Masan Group was recognized with two prestigious honors.
  • The company was bestowed with the title of "Best Companies to Work for in Asia 2023," and it also got the special award category for "Diversity, Equity, and Inclusion" in acknowledgment of its commitment to fostering a diverse, equal, and inclusive working environment.
  • The "Best Place to Work in Asia" award is a highly esteemed international accolade presented annually by HR Asia, the premier magazine on human resources in Asia.
  • It aims to assess and recognize businesses with outstanding HR policies, attractive remuneration packages, and the most exemplary working environments in the region.

KULR Technology Group Reports First Quarter 2023 Financial Results

Retrieved on: 
Monday, May 15, 2023
Advertising, SG, Marketing, Aviation, JPL (Integrated Communications, Inc.), State Farm Research and Development Center, Holocene, Goldman Sachs, Suretrack Contracts Services, KULR, Patent, NASA, Administration, SAN, Department of Defense Architecture Framework, CFO, Growth, Research and development, Silicon, R, Research, Bank, NYSE, Video game, Pharmaceutical industry, Mobile phone, Development

SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a leading energy management platform company accelerating the global transition to a sustainable electrification economy, today reported results for the first quarter ended March 31, 2023.

Key Points: 
  • SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a leading energy management platform company accelerating the global transition to a sustainable electrification economy, today reported results for the first quarter ended March 31, 2023.
  • Revenues: In the first quarter ended March 31, 2023, revenue increased to $1.8 million from $0.2 million reported in the same period last year.
  • Gross Margins: Gross margin was 37% in the quarter ended March 31, 2023, compared to 39% in the same period last year.
  • First Quarter 2023 and Recent Operational Highlights:
    Awarded a $1.13M U.S. Army contract to develop next generation high-energy battery packs with KULR ONE Design Solutions.

Student Researchers Use UAE-Developed Generative AI Technology to Find New Brain Tumor Drug Targets

Retrieved on: 
Tuesday, May 2, 2023
Spanish National Center for Biotechnology, Pine Crest School, Neuron, Drug development, GBM, Drug discovery, Sevenoaks School, Survival, Ageing, Cancer, National Center for Biotechnology Information, Brain, Research, Gene expression, Biomarker, Cell, Aging Research and Drug Discovery, Doctor of Philosophy, Glioblastoma, Science, Student, GLUD1, Shanghai High School International Division, Patient, Dark Ages, Gene Expression Omnibus, Insilico Medicine, Neuroscience, Artificial intelligence, Biology, Growth, AI, Longevity, Gene, State Farm Research and Development Center, Medicine, CNGA3, Molecular Modeling Database, Mobile phone, Medical device, Pharmaceutical industry, In silico

GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.

Key Points: 
  • GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.
  • Olsen, a student at Sevenoaks School in Kent, UK, began interning at Insilico Medicine in 2021, after discovering her interest in neurobiology and technology.
  • He discovered generative AI drug discovery company Insilico Medicine whose founder and CEO, Alex Zhavoronkov, PhD, connected him with Olsen.
  • It really kick-started my entire career.”
    “I am truly impressed by the commitment of these young researchers,” says Zhavoronkov.

Swift Current Energy Ramps Up Construction of 800 MW Double Black Diamond Solar Project with McCarthy Building Companies

Retrieved on: 
Wednesday, March 29, 2023
Diamond, Constellation, Workforce, Insurance, Climate, Partnership, Piste, Mount Scott (Canada), Engineering, State Farm Research and Development Center, EPC, Black Diamond, First Solar, Midway International Airport, Research, O'Hare International Airport, Movement, Swift Current, Engineering, procurement, and construction, City, PPG, DEI, Growth, McCarthy, Environment, State Farm, Renewable energy

BOSTON and HOUSTON, March 29, 2023 /PRNewswire/ -- Swift Current Energy ("Swift Current") is ramping up construction this spring for its Double Black Diamond solar project in central Illinois. The company has contracted St. Louis-based McCarthy Building Companies ("McCarthy") as the Engineering, Procurement and Construction (EPC) contractor. Swift Current has also selected American-based First Solar to provide the 800 MWdc solar modules for the project and American-based Nextracker to provide the smart solar tracker solutions for the project. The majority of the project's 1.6 million solar panels will be manufactured in the United States.

Key Points: 
  • BOSTON and HOUSTON, March 29, 2023 /PRNewswire/ -- Swift Current Energy ("Swift Current") is ramping up construction this spring for its Double Black Diamond solar project in central Illinois.
  • Swift Current has also selected American-based First Solar to provide the 800 MWdc solar modules for the project and American-based Nextracker to provide the smart solar tracker solutions for the project.
  • In coordination with local unions, the project is hiring approximately 435 craft workers to construct the Double Black Diamond solar project, with crews having already begun sitework.
  • Additionally, State Farm and PPG will purchase zero-emission, renewable energy from the Double Black Diamond solar project.